RocketTickers

InflaRx Announces Positive Initial Data from Ongoing Phase IIa O

Long
NASDAQ:IFRX   InflaRx N.V.
IFRX: InflaRx N.V.
2020-02-26 07:30:10
InflaRx Announces Positive Initial Data from Ongoing Phase IIa Open Label Study with IFX-1 in Patients Suffering from Pyoderma Gangraenosum
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.